drugset / Trial / NCT04379492

A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19

NCT04379492

RandomizedParallel-groupDouble-blindTreatment

Summary

This study is being done to see if hydroxychloroquine is an effective treatment for COVID-19.

Timeline

Start
2020-05-05
Primary completion
2020-09-25
Completion
2020-09-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxychloroquine Small molecule 200 mg Oral

Indications